AndJu - Company finances
|
EUR
|
2024
From: 2024-01-29
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|
|
Financial data
|
||
| Sales revenue | 3,594 | 86,340 |
| Profit before tax | 1,506 | 7,491 |
| Net profit | 1,506 | 7,042 |
| Equity | 1,506 | 8,548 |
| Liabilities | 14,364 | 456 |
| Non-current assets | 117 | 456 |
| Current assets | 15,753 | 8,548 |
| Total assets | 15,870 | 9,004 |
|
Taxes paid
|
||
| STI taxes | 343 | 1,067 |
|
Financial indicators
|
||
| Revenue change y/y | - | +2302.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 9.5% | 78.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 100.0% | 82.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 41.9% | 8.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 41.9% | 8.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 9.5 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
AndJu - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-02-24 | 2026-03-31 | 287.46 |
AndJu - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
AndJu, MB (code 306670149) is a Small partnership engaged in retail sale of pharmaceutical products. In the latest financial year, 2025, revenue reached EUR 86.3K and net profit was EUR 7.0K, giving a net margin of 8.2%. The business expanded sharply from 2024, when revenue amounted to EUR 3.6K and net profit to EUR 1.5K; profitability was higher then, with a 41.9% margin. The 2025 results therefore show much stronger turnover, but also a more normalised margin level. The balance sheet remained very light at the end of 2025, with total assets of EUR 9.0K, equity of EUR 8.5K and liabilities of EUR 456, indicating a highly equity-funded structure and minimal leverage. Asset turnover stood at 9.59x, reflecting intensive use of a small asset base. Return indicators were high, but they should be interpreted in the context of the company’s small scale. Overall, 2025 was a year of rapid revenue growth, continued profitability and a conservative balance-sheet position.